About Us | Contact Us | Expert Panel | Partners

Browsing: Viral > HIV / AIDS

HIV/AIDs news and research

Human immunodeficiency virus (HIV) attacks the body's immune system; left untreated it can lead to the AIDS (acquired immunodeficiency syndrome).

Diagnosis

11 June, 2019 1 Quality control in HIV point-of-care testing – an interview with David Padley

In this interview we speak to David Padley from the National Institute for Biological Standards and Control about his recent poster ‘Point-of-Care testing for HIV: specialist quality control materials are a necessity’, presented at ECCMID 2019.

News

30 May, 2019 0 FDA rejects Nabriva’s antibiotic Contepo for complicated UTIs: May’s industry headlines

Take a look at this month’s industry headlines including US FDA approvals for Mavyret (hepatitis C) and Dengvaxia, a rejection for Contepo and profits for Gilead Sciences.

HIV / AIDS

22 May, 2019 0 Early antiretroviral treatment could help develop long-term immune memory

Early antiretroviral treatment in people with HIV infection could allow the generation of more functional and persistent CD8 T cell responses. The results, which suggest a long-term immune memory, could have implications for HIV vaccine development.

HIV / AIDS

9 May, 2019 0 Slow-release delivery strategies provide better immunity for HIV vaccine

Delivering HIV vaccines via slow-release methods has enhanced the protective immune response in preclinical models, according to new research.

HIV / AIDS

1 May, 2019 0 Who should take the lead in prescribing PrEP?

Healthcare practitioners have split opinions on whether primary care doctors or other providers should take the lead on prescribing PrEP for HIV prevention, according to new research.

News

30 April, 2019 0 Positive opinions from US FDA and EMA for ViiV Healthcare’s Dovato®: April’s industry headlines

Take a look at this month’s industry headlines including news from ViiV Healthcare on long-acting and single dose formulations, sales for Eli Lilly and the possible development of a plague vaccine.

HIV / AIDS

10 April, 2019 0 HIV: new imaging reveals targets on the viral envelope

New research describes the use of small-molecule CD4 mimetic compounds that force HIV to undergo conformational changes, exposing normally hidden parts of the envelope and potential new targets.

Hepatitis

3 April, 2019 0 A peek behind the paper – Bryan Tolentino on HIV and hepatitis C coinfection

Take a look behind the scenes of a recent Future Virology review entitled ‘An update on the management of hepatitis C virus and human immunodeficiency virus coinfection’, as we ask the authors about their inspiration and the future of this field.

News

28 March, 2019 0 Phase III study of Novavax’s RSV vaccine fails primary objective: March’s industry headlines

Take a look at this month’s industry headlines including news on Sanofi’s Dengvaxia® vaccine from the USA and the Philippines, clinical trial results for RSV vaccines and HIV injectables and new acquisitions for Merck.

News

7 March, 2019 0 CROI 2019: key news stories

Find out more about the headlines from the Conference on Retroviruses and Opportunistic Infections 2019 (CROI) in our round-up of conference news.

1 2 3 … 9 Next

Microbiome therapeutics – the pipeline for C. difficile infection

Browsing: Viral > HIV / AIDS

HIV/AIDs news and research

Thank you for subscribing, your log-in details have been emailed to you.